CSL to lift the hood on its big Vifor acquisition on Monday
CSL investors have been waiting to hear about the blood product giant’s strategy for Vifor after a $US12bn acquisition.
Source: afr.com
Stay updated with breaking news from Vifor Ferinject. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CSL investors have been waiting to hear about the blood product giant’s strategy for Vifor after a $US12bn acquisition.